Table 2.
Numbers (percentages) of men and women using asthma drugs
| Additional drugs
|
|||
|---|---|---|---|
| β agonist | Inhaled steroid | Oral steroid | |
| Women (n=134) | |||
| Total* | 115 (86) | 89 (66) | 40 (30)† |
| β agonist and | 26 (19)‡ | 77 (57) | 37 (28)† |
| Inhaled steroid and | — | — | 34 (25)† |
| β agonist, inhaled steroid, and | — | — | 31 (23)† |
| Men (n=103) | |||
| Total* | 95 (92) | 65 (63) | 9 (9)† |
| β agonist and | 24 (23)‡ | 61 (59) | 8 (8)† |
| Inhaled steroid and | — | — | 7 (7)† |
| β agonist, inhaled steroid, and | — | — | 7 (7)† |
The three treatments are not mutually exclusive; 106 (29%) subjects took miscellaneous asthma drugs such as theophylline.
P<0.01 for comparison between men and women.
β agonist only.